Correction: Rituximab in the treatment of progressive interstitial lung disease associated with the antisynthetase syndrome

• Javier Narvaez,
• Elena Canadillas,
• Ivan Castellvi,
• Juan Jose Alegre,
• Vanesa Vicens‑Zygmunt,
• Guadalupe Bermudo,
• Paola Vidal-Montal,
• Maria Molina Molina,
• Joan Miquel Nolla

Affiliations

Javier Narvaez

Department of Rheumatology, Hospital Universitario de Bellvitge. Bellvitge Biomedical Research Institute (IDIBELL)

Elena Canadillas

Department of Rheumatology, Hospital Cl?nico, Universitario Lozano Blesa

Ivan Castellvi

Department of Rheumatology. Hospital, Universitario de la Santa Creu i Sant Pau

Juan Jose Alegre

Department of Rheumatology. Hospital, Universitario Dr Peset

Vanesa Vicens‑Zygmunt

Interstitial Lung Disease Unit, Department of Pneumology. Hospital, Universitario de Bellvitge. Bellvitge Biomedical Research Institute (IDIBELL)

Guadalupe Bermudo

Interstitial Lung Disease Unit, Department of Pneumology. Hospital, Universitario de Bellvitge. Bellvitge Biomedical Research Institute (IDIBELL)

Paola Vidal-Montal

Department of Rheumatology, Hospital Universitario de Bellvitge. Bellvitge Biomedical Research Institute (IDIBELL)

Maria Molina Molina

Interstitial Lung Disease Unit, Department of Pneumology. Hospital, Universitario de Bellvitge. Bellvitge Biomedical Research Institute (IDIBELL)

Joan Miquel Nolla

Department of Rheumatology, Hospital Universitario de Bellvitge. Bellvitge Biomedical Research Institute (IDIBELL)